Validation of Serological Testing for Anti-Treponema pallidum from Postmortem Blood on the Siemens-BEP®-III Automatic System | Zendy

Ulrich Kalus | Zendy; Ina Wilkemeyer | Zendy; Axel Pruß | Zendy; G. Caspari | Zendy

Open Access

Validation of Serological Testing for Anti-Treponema pallidum from Postmortem Blood on the Siemens-BEP®-III Automatic System

Author(s) -

Ulrich Kalus,

Ina Wilkemeyer,

Axel Pruß,

G. Caspari

Publication year - 2013

Publication title -

transfusion medicine and hemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.971

H-Index - 39

eISSN - 1660-3818

pISSN - 1660-3796

DOI - 10.1159/000354070

Subject(s) - hemolysis , medicine , serology , treponema , pathology , hemoglobin , antibody , immunology , syphilis , human immunodeficiency virus (hiv)

Infectious disease marker testing is obligatory for the release of human tissue for transplantation. Most CE-marked tests are not validated for postmortem blood. In a previous study we have validated the testing for anti-HIV-1/2, anti-HCV, HBsAg, and anti-HBc. Here, we present the validation of testing for antibodies against T. pallidum, which is the last marker obligatory for tissue release for transplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research